Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Baloxavir marboxil (S-033188) is a novel cap-dependent endonuclease inhibitor for the treatment of influenza A and B virus infections.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 10,000 | |||
50 mg | 在庫あり | ¥ 12,500 | |||
100 mg | 在庫あり | ¥ 21,000 | |||
250 mg | 在庫あり | ¥ 43,500 | |||
500 mg | 在庫あり | ¥ 79,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,500 |
説明 | Baloxavir marboxil (S-033188) is a novel cap-dependent endonuclease inhibitor for the treatment of influenza A and B virus infections. |
別名 | S-033188 |
分子量 | 571.55 |
分子式 | C27H23F2N3O7S |
CAS No. | 1985606-14-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (104.98 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Baloxavir marboxil 1985606-14-1 Microbiology/Virology Influenza Virus S-033188 inhibit S033188 S 033188 Inhibitor inhibitor